HeartSciences Inc.
HSCS
$3.03
$0.217.45%
NASDAQ
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 26.32% | -56.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.32% | -56.82% | |||
| Cost of Revenue | 25.00% | -57.89% | |||
| Gross Profit | 27.27% | -56.00% | |||
| SG&A Expenses | 53.49% | -11.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.65% | -2.53% | |||
| Operating Income | -10.63% | 2.41% | |||
| Income Before Tax | -14.39% | 1.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.39% | 1.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.39% | 1.88% | |||
| EBIT | -10.63% | 2.41% | |||
| EBITDA | -10.68% | 2.40% | |||
| EPS Basic | 46.37% | 19.39% | |||
| Normalized Basic EPS | 46.37% | 19.39% | |||
| EPS Diluted | 46.37% | 19.39% | |||
| Normalized Diluted EPS | 46.37% | 19.39% | |||
| Average Basic Shares Outstanding | 113.31% | 21.72% | |||
| Average Diluted Shares Outstanding | 113.31% | 21.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||